We succeed by working together. In order to bring innovative therapeutics through an unbroken and fully funded path from concept to proven treatment of human diseases, we leverage the unique positions, skills, ethos and investing power of our partners. Read more about the individual strengths they bring to the table.
Tri-Institutional Therapeutics Discovery Institute
TDI connects researchers from Memorial Sloan Kettering Cancer Center, The Rockefeller University and Weill Cornell Medicine with collaborators from across the globe to remove the barriers that impede drug discovery in academic settings. Together with our partner, Takeda, we enable the discovery of next-generation drugs by empowering our faculty with the tools, technology, and expertise to meet this extraordinary challenge.
Our academic researchers excel at discovering new biological pathways that are responsible for disease initiation and progression. However, the chasm between these biological insights and impact on patients can seem overwhelming. In order to effectively translate novel insights into drugs, academic scientists must have access to cutting-edge drug discovery tools, technologies, and expertise.
TDI’s primary role in the community is to provide the bridge between basic academic discovery and real-world application. At TDI, we provide industry-quality drug development support for each project in our portfolio. We leverage the resources of our three institutions, our industry partner, Takeda Pharmaceuticals, and a global network of collaborators to help our academic partners rapidly advance their groundbreaking discoveries along the path from bench to bedside. For more information, please visit www.tritdi.org.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center — the world’s oldest and largest private cancer center — has devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs. Today, we are one of 45 National Cancer Institute–designated Comprehensive Cancer Centers, with state-of-the-art science flourishing side by side with clinical studies and treatment. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available as we work to discover more-effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan Kettering has an impact on cancer treatment and biomedical research around the world. For more information, please visit www.mskcc.org.
The Rockefeller University
The Rockefeller University is the world’s leading biomedical research university and is dedicated to conducting innovative, high-quality research to improve the understanding of life for the benefit of humanity. Our 81 laboratories conduct research in neuroscience, immunology, biochemistry, genomics and many other areas, and a community of over 2,000 faculty, students, postdocs, technicians, clinicians and administrative personnel work on our 14-acre Manhattan campus. Our unique approach to science has led to some of the world’s most revolutionary and transformative contributions to biology and medicine. During Rockefeller’s 115-year history, 24 of our scientists have won Nobel Prizes, 22 have won Albert Lasker Medical Research Awards and 20 have garnered the National Medal of Science, the highest science award given by the United States. For more information, please visit www.rockefeller.edu.
Weill Cornell Medicine
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine—faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization—are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies.
Located in the heart of the Upper East Side’s scientific corridor, Weill Cornell Medicine’s powerful network of collaborators extends to its parent university Cornell University; to Qatar, where an international campus offers a U.S. medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide comprehensive patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian/Lower Manhattan Hospital and NewYork-Presbyterian/Queens. Weill Cornell Medicine maintains major affiliations with Memorial Sloan-Kettering Cancer Center, The Rockefeller University, the Hospital for Special Surgery and Houston Methodist. Weill Cornell Medicine is accredited by the Liaison Committee for Medical Education of the American Medical Association and the Association of American Medical Colleges. For more information, please visit www.weill.cornell.edu.
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited (TSE: 4502) is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda. More than 30,000 Takeda employees are committed to improving quality of life for patients, working with our partners in health care in more than 70 countries. For more information, please visit www.takeda.com/news/.
Bay City Capital LLC
Bay City Capital LLC is a life sciences investment firm with a global diversified strategy ranging from seed stage to public companies, largely focused on the development of breakthrough therapeutics. For more information, please visit www.baycitycapital.com.
Deerfield Management Company
Deerfield is an investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.